Home LiteratureArticle Details
PMID: 8648693 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Longitudinal studies of viral sequence, viral phenotype, and immunologic parameters of human immunodeficiency virus type 1 infection in perinatally infected twins with discordant disease courses.

Journal of virology ·Vol. 70 ·No. 6 ·1996-06-00 ·Pages 3589-98

Hutto C, Zhou Y, He J, Geffin R, Hill M, Scott W, Wood C

Abstract

Perinatal human immunodeficiency virus type 1 (HIV-1) infections cause a broad spectrum of clinical disease and are variable in both the age of the patient at onset of serious disease and the progression of the clinical course. Heterozygotic perinatally infected twins with a marked difference in their clinical courses were monitored during the first 2 years of life. Twin B, the second-born twin, developed AIDS by 6 months of age and died at 22 months of age, while twin A remained minimally symptomatic through the first 2 years. Sequential blood specimens were obtained from the twins in order to characterize the immunologic properties of the children and the phenotypes and genotypes of the HIV-1 isolates at various times. Twin A developed neutralizing antibodies and a high-level antibody-mediated cellular cytotoxicity (ADCC) response, while twin B had no neutralizing antibody and a much lower ADCC response. The virus isolates obtained from the two children at various time points proliferated equally well in peripheral blood mononuclear cells, were nonsyncytium inducing, and could not infect established T-cell lines. They differed in their ability to infect primary macrophages. In parallel to the biological studies, the HIV-1 tat and part of the env gene sequences of the longitudinal isolates at four time points were determined. Sequences of virus from both twins at different time points were highly conserved; the viruses evolved at a similar rate until the last analyzed time point, at which there was a dramatic increase in sequence diversity for the sicker child, especially in the tat gene. Our results show that the viruses isolated at different times do not have significant changes in growth properties. The absence or low levels of neutralizing antibodies may correlate with disease progression in the twins.

MeSH Terms
Acquired Immunodeficiency Syndrome/immunology,virology Adult Amino Acid Sequence Antibody-Dependent Cell Cytotoxicity Base Sequence Child, Preschool Cloning, Molecular Diseases in Twins Female HIV-1/genetics,growth & development,immunology Humans Infant Infectious Disease Transmission, Vertical Longitudinal Studies Molecular Sequence Data Phenotype Pregnancy Pregnancy Complications, Infectious
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Hutto C
Department of Pediatrics, University of Miami School of Medicine, Florida 33136, USA.
Zhou Y
He J
Geffin R
Hill M
Scott W
Wood C
References (38)
38 references, click to expand
  1. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality.
    Lancet. 1989 May 6;1(8645):983-5 PMID: 2565516
  2. Clinical significance of human immunodeficiency virus type 1 phenotypes in infected children.
    J Infect Dis. 1994 Mar;169(3):491-5 PMID: 7908924
  3. Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus.
    Proc Natl Acad Sci U S A. 1989 Nov;86(21):8575-9 PMID: 2813413
  4. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms.
    Am J Dis Child. 1990 Nov;144(11):1210-5 PMID: 1978551
  5. The viral envelope gene is involved in macrophage tropism of a human immunodeficiency virus type 1 strain isolated from brain tissue.
    J Virol. 1990 Dec;64(12):6148-53 PMID: 2243391
  6. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene.
    Nature. 1991 Jan 10;349(6305):167-9 PMID: 1986308
  7. Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120.
    J Virol. 1991 Dec;65(12):6931-41 PMID: 1658383
  8. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle.
    J Virol. 1992 Mar;66(3):1717-25 PMID: 1371173
  9. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants.
    Science. 1992 Feb 28;255(5048):1134-7 PMID: 1546316
  10. Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.
    J Virol. 1992 Apr;66(4):1875-83 PMID: 1548744
  11. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo.
    J Virol. 1992 Apr;66(4):2577-82 PMID: 1548783
  12. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule.
    J Virol. 1992 May;66(5):3183-7 PMID: 1560543
  13. Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian Register for HIV Infections in Children.
    Lancet. 1992 May 23;339(8804):1249-53 PMID: 1349667
  14. Convergent and divergent sequence evolution in the surface envelope glycoprotein of human immunodeficiency virus type 1 within a single infected patient.
    Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4835-9 PMID: 1594583
  15. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories.
    J Clin Microbiol. 1992 Jul;30(7):1787-94 PMID: 1629336
  16. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism.
    J Virol. 1992 Nov;66(11):6547-54 PMID: 1404602
  17. Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease.
    Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10247-51 PMID: 1438212
  18. Evolution of sequence divergence among human immunodeficiency virus type 1 isolates derived from a blood donor and a recipient.
    Pediatr Res. 1993 Jan;33(1):36-42 PMID: 8433858
  19. Diversification of HIV-1 strains after infection from a unique source.
    AIDS Res Hum Retroviruses. 1993 Feb;9(2):153-7 PMID: 8457382
  20. Ontogeny of anti-human immunodeficiency virus (HIV) antibody production in HIV-1-infected infants.
    Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2340-4 PMID: 8460144
  21. A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism.
    J Virol. 1993 Jun;67(6):3649-52 PMID: 8497073
  22. Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo.
    J Virol. 1993 Jul;67(7):3951-60 PMID: 8510212
  23. Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates.
    J Infect Dis. 1993 Jul;168(1):207-10 PMID: 8515110
  24. Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children.
    Clin Exp Immunol. 1993 Jul;93(1):56-64 PMID: 8324904
  25. Ontogeny of the humoral immune response to human immunodeficiency virus type 1 in infants.
    J Infect Dis. 1993 Aug;168(2):288-91 PMID: 8335966
  26. Genomic human immunodeficiency virus type 1 RNA variation in mother and child following intra-uterine virus transmission.
    J Gen Virol. 1993 Sep;74 ( Pt 9):1747-56 PMID: 8376956
  27. Replication and tropism of human immunodeficiency virus type 1 as predictors of disease outcome in infants with vertically acquired infection.
    J Pediatr. 1993 Dec;123(6):929-36 PMID: 7901357
  28. Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery.
    N Engl J Med. 1994 Feb 3;330(5):308-12 PMID: 7904046
  29. Persistence of multiple maternal genotypes of human immunodeficiency virus type I in infants infected by vertical transmission.
    J Clin Invest. 1994 Jan;93(1):380-90 PMID: 8282808
  30. Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120.
    J Virol. 1994 Apr;68(4):2503-12 PMID: 8139032
  31. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression.
    J Virol. 1994 Jul;68(7):4400-8 PMID: 7515972
  32. Features of HIV-1 that could influence maternal-child transmission.
    JAMA. 1994 Aug 10;272(6):467-74 PMID: 8040983
  33. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays.
    J Virol. 1994 Oct;68(10):6672-83 PMID: 8084001
  34. Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants.
    J Infect Dis. 1994 Nov;170(5):1279-84 PMID: 7963727
  35. DNA sequencing with chain-terminating inhibitors.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 PMID: 271968
  36. Standardized microtiter assay for determination of syncytium-inducing phenotypes of clinical human immunodeficiency virus type 1 isolates.
    J Clin Microbiol. 1994 Sep;32(9):2291-4 PMID: 7814561
  37. Protecting HIV databases.
    Nature. 1995 Nov 16;378(6554):242-4 PMID: 7477340
  38. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. New York City Collaborative Study of Maternal HIV Transmission and Montefiore Medical Center HIV Perinatal Transmission Study Group.
    N Engl J Med. 1989 Jun 22;320(25):1649-54 PMID: 2725615
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1996-06-00
Pages
3589-98
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC190234
Subset
IM
Grants
NIAID NIH HHS · AI30356 · United States
NCI NIH HHS · CA62810 · United States
NICHD NIH HHS · HD26619 · United States
Databases
GENBANK
U47562, U47563, U47564, U47565, U47566, U47567, U47568, U47569, U47570, U47571, U47572, U47573, U47574, U47575, U47576, U47577, U47578, U47579, U47580, U47581, U47582, U47583, U47584, U47585, U47586, U47587, U47588, U47589, U47590, U47591
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com